![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.sanofi.com/en/media-room/press-releases/2024/2024-07-17-21-27-40-2914957
https://www.prnewswire.com/news-releases/sobi-q2-2024-report-strong-delivery-driven-by-robust-portfolio-performance-302197918.html
https://www.fiercepharma.com/pharma/sobi-angling-become-major-hematology-player-sees-momentum-across-key-brands
https://www.prnewswire.com/news-releases/the-board-of-directors-of-sobi-exercises-authorisation-for-repurchase-of-shares-for-the-purpose-of-securing-the-companys-commitments-under-incentive-programmes-302197159.html
https://www.prnewswire.com/news-releases/invitation-sobis-q2-2024-report-302188900.html
https://pharmaphorum.com/news/sobi-gets-eu-okay-long-acting-haemophilia-drug
https://www.globenewswire.com/news-release/2024/05/24/2888173/0/en/Sobi-to-present-new-myelofibrosis-data-at-the-ASCO-2024-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/24/2888151/0/en/Sobi-Receives-US-FDA-Fast-Track-Designation-for-Emapalumab-lzsg-being-investigated-in-Macrophage-Activation-Syndrome.html
https://www.prnewswire.com/news-releases/positive-data-from-phase-2-noble-study-of-pegcetacoplan-presented-as-late-breaker-at-era-congress-302155222.html
https://www.prnewswire.com/news-releases/bulletin-from-sobis-annual-general-meeting-agm-302145122.html